日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies

新型PI3Kδ抑制剂roginolisib与venetoclax在血液系统恶性肿瘤中具有协同作用

Sasi, Binu Kandathilparambil; Tarantelli, Chiara; Martindale, Stephen; Civanelli, Elisa; Cannas, Eleonora; Sartori, Giulio; Arribas, Alberto J; Fernandes, Stacey M; Shupe, Samantha J; Machado, John-Hanson; Tyekucheva, Svitlana; Ren, Yue; Lahn, Michael; Van der Veen, Lars; Di Conza, Giusy; Bertoni, Francesco; Brown, Jennifer R

KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas.

KAT/3BP:一种针对代谢的靶向药物,对侵袭性 B 细胞淋巴瘤具有单药和联合治疗活性

Tarantelli Chiara, Spriano Filippo, Civanelli Elisa, Aresu Luca, Risi Giorgia, Cannas Eleonora, Kayali Omar, Cascione Luciano, Arribas Alberto J, Stathis Anastasios, Ko Young H, Bertoni Francesco

Screening the Irish Marine Biorepository Identifies a New Bryostatin Analog as Potent Inhibitor of Activated B-Cells Diffuse Large B-Cell Lymphoma

对爱尔兰海洋生物样本库的筛选发现了一种新的布里奥司他汀类似物,该类似物是活化B细胞弥漫性大B细胞淋巴瘤的有效抑制剂。

Jennings, Laurence K; Spriano, Filippo; Reddy, Maggie M; Cascione, Luciano; Civanelli, Elisa; Rinaldi, Andrea; Bertoni, Francesco; Thomas, Olivier P